Overview Lupin is comprised of a fast growing, innovative and robust team of manufacturing, Research and Development and commercial divisions. Together these entities make up the generic and branded U.S. business. Lupin has a significant generic pipeline, and a branded focus on women’s health. Our first Research and Development facility in the US is located in Coral Springs, Florida which focuses on generic and branded orally inhaled and nasal drug products. Somerset, New Jersey is home to one of Fifteen commercial manufacturing sites globally and the only commercial manufacturing facility in the United States for Lupin, as well as additional Research and Development teams. Lupin is prided on being people-focused and centered around how impactful we are with our customers. Dollars are not a measure of success but rather the people we help along the way. The Director, Market Access – Generics Business will be a key member of Lupin’s Commercial and Biosimilar team, responsible for developing and executing market access strategies for Lupin’s generic specialty portfolio including biosimilars and 505b2 products. This role will focus on assessing payer and GPO opportunities, providing strategic insights into customer decision-making, and ensuring optimal access for Lupin’s specialty products across all relevant channels. The position requires close coordination with internal departments such as Finance, Contract Analytics & Distribution, Legal, Trade and Distribution, and Commercial Operations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
501-1,000 employees